Avalide

This page contains recent news articles, when available, and an overview of Avalide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Avalide
(when available)

Pharmacology and use:
Irbesartan, an angiotensin II receptor antagonist similar to losartan and valsartan, is used alone or with hydrochlorothiazide to treat hypertension For the treatment of hypertension.

Mechanism Of Action:
Irbesartan antagonizes angiotensin II, the primary vasoactive hormone of the renin-angiotensin system, at the AT1 receptor subtype. As angiotensin II is vasoconstrictor which stimulates aldosterone secretion by the adrenal gland, blockage of its effects results in a decrease in systemic vascular resistance.

News Articles on Irbesartan

Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter  -  ‎Oct 22, 2009‎
2008 Three Months Ended September 30, BioPharmaceuticals Cardiovascular Plavix $ 1554 $ 1439 8 % $ 1406 $ 1263 11 % 4 % Avapro/Avalide 329 334 (1 )% 186 189 ... Reuters

Brand Names/Synonyms:
Avalide is also known by the following brand names and/or synonymsAvalide; Avapro; CHEMBANK1635; Irbesarran; Irbesartan; Irbesartan [Usan:Inn]; Lrbesartan

Drug Category:
Avalide is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin II Receptor Antagonists; ATC:C09CA04

Dosage Forms:
Oral tablets

Absorption:
60-80%

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
3-butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy